ID OXYR_HUMAN Reviewed; 389 AA. AC P30559; Q15071; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 03-APR-2007, sequence version 2. DT 24-JAN-2024, entry version 195. DE RecName: Full=Oxytocin receptor; DE Short=OT-R; GN Name=OXTR; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-218. RC TISSUE=Uterus; RX PubMed=1313946; DOI=10.1038/356526a0; RA Kimura T., Tanizawa O., Mori K., Brownstein M.J., Okayama H.; RT "Structure and expression of a human oxytocin receptor."; RL Nature 356:526-529(1992). RN [2] RP ERRATUM OF PUBMED:1313946, AND SEQUENCE REVISION. RA Kimura T., Tanizawa O., Mori K., Brownstein M.J., Okayama H.; RL Nature 357:176-176(1992). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-218. RC TISSUE=Ovary; RA Kopatz S.A., Aronstam R.S., Sharma S.V.; RT "cDNA clones of human proteins involved in signal transduction sequenced by RT the Guthrie cDNA resource center (www.cdna.org)."; RL Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-308. RX PubMed=7798245; DOI=10.1016/s0021-9258(18)31656-9; RA Inoue T., Kimura T., Azuma C., Inazawa J., Takemura M., Kikuchi T., RA Kubota Y., Ogita K., Saji F.; RT "Structural organization of the human oxytocin receptor gene."; RL J. Biol. Chem. 269:32451-32456(1994). CC -!- FUNCTION: Receptor for oxytocin. The activity of this receptor is CC mediated by G proteins which activate a phosphatidylinositol-calcium CC second messenger system. CC -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein. CC -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family. CC Vasopressin/oxytocin receptor subfamily. {ECO:0000255|PROSITE- CC ProRule:PRU00521}. CC -!- WEB RESOURCE: Name=Wikipedia; Note=Oxytocin entry; CC URL="https://en.wikipedia.org/wiki/Oxytocin"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X64878; CAA46097.1; -; mRNA. DR EMBL; AY389507; AAQ91333.1; -; mRNA. DR EMBL; X80282; CAA56562.1; -; Genomic_DNA. DR CCDS; CCDS2570.1; -. DR PIR; A55493; A55493. DR RefSeq; NP_000907.2; NM_000916.3. DR RefSeq; XP_011532064.1; XM_011533762.2. DR PDB; 6TPK; X-ray; 3.20 A; A=35-356. DR PDB; 7QVM; EM; 3.25 A; R=1-359. DR PDB; 7RYC; EM; 2.90 A; O=1-389. DR PDBsum; 6TPK; -. DR PDBsum; 7QVM; -. DR PDBsum; 7RYC; -. DR AlphaFoldDB; P30559; -. DR EMDB; EMD-14180; -. DR EMDB; EMD-24733; -. DR SMR; P30559; -. DR BioGRID; 111061; 14. DR ELM; P30559; -. DR IntAct; P30559; 18. DR MINT; P30559; -. DR STRING; 9606.ENSP00000324270; -. DR BindingDB; P30559; -. DR ChEMBL; CHEMBL2049; -. DR DrugBank; DB09059; Atosiban. DR DrugBank; DB01282; Carbetocin. DR DrugBank; DB00107; Oxytocin. DR DrugBank; DB13929; Relcovaptan. DR DrugBank; DB00067; Vasopressin. DR DrugCentral; P30559; -. DR GuidetoPHARMACOLOGY; 369; -. DR TCDB; 9.A.14.10.4; the g-protein-coupled receptor (gpcr) family. DR GlyCosmos; P30559; 3 sites, No reported glycans. DR GlyGen; P30559; 3 sites. DR iPTMnet; P30559; -. DR PhosphoSitePlus; P30559; -. DR SwissPalm; P30559; -. DR BioMuta; OXTR; -. DR DMDM; 143811431; -. DR MassIVE; P30559; -. DR MaxQB; P30559; -. DR PaxDb; 9606-ENSP00000324270; -. DR PeptideAtlas; P30559; -. DR ProteomicsDB; 54722; -. DR Antibodypedia; 10144; 410 antibodies from 35 providers. DR CPTC; P30559; 2 antibodies. DR DNASU; 5021; -. DR Ensembl; ENST00000316793.8; ENSP00000324270.2; ENSG00000180914.11. DR GeneID; 5021; -. DR KEGG; hsa:5021; -. DR MANE-Select; ENST00000316793.8; ENSP00000324270.2; NM_000916.4; NP_000907.2. DR UCSC; uc003brc.4; human. DR AGR; HGNC:8529; -. DR CTD; 5021; -. DR DisGeNET; 5021; -. DR GeneCards; OXTR; -. DR HGNC; HGNC:8529; OXTR. DR HPA; ENSG00000180914; Tissue enriched (breast). DR MalaCards; OXTR; -. DR MIM; 167055; gene. DR neXtProt; NX_P30559; -. DR OpenTargets; ENSG00000180914; -. DR PharmGKB; PA32858; -. DR VEuPathDB; HostDB:ENSG00000180914; -. DR eggNOG; KOG3656; Eukaryota. DR GeneTree; ENSGT01050000244882; -. DR HOGENOM; CLU_009579_15_3_1; -. DR InParanoid; P30559; -. DR OMA; AFIMCWT; -. DR OrthoDB; 2879183at2759; -. DR PhylomeDB; P30559; -. DR TreeFam; TF106499; -. DR PathwayCommons; P30559; -. DR Reactome; R-HSA-388479; Vasopressin-like receptors. DR Reactome; R-HSA-416476; G alpha (q) signalling events. DR SignaLink; P30559; -. DR SIGNOR; P30559; -. DR BioGRID-ORCS; 5021; 15 hits in 1164 CRISPR screens. DR GeneWiki; Oxytocin_receptor; -. DR GenomeRNAi; 5021; -. DR Pharos; P30559; Tclin. DR PRO; PR:P30559; -. DR Proteomes; UP000005640; Chromosome 3. DR RNAct; P30559; Protein. DR Bgee; ENSG00000180914; Expressed in decidua and 142 other cell types or tissues. DR ExpressionAtlas; P30559; baseline and differential. DR GO; GO:0005912; C:adherens junction; IEA:Ensembl. DR GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl. DR GO; GO:0005902; C:microvillus; IEA:Ensembl. DR GO; GO:0005886; C:plasma membrane; TAS:Reactome. DR GO; GO:0004990; F:oxytocin receptor activity; IBA:GO_Central. DR GO; GO:0042277; F:peptide binding; IBA:GO_Central. DR GO; GO:0017046; F:peptide hormone binding; IEA:Ensembl. DR GO; GO:0005000; F:vasopressin receptor activity; IBA:GO_Central. DR GO; GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc. DR GO; GO:0032870; P:cellular response to hormone stimulus; IBA:GO_Central. DR GO; GO:0048565; P:digestive tract development; IEA:Ensembl. DR GO; GO:0042755; P:eating behavior; IEA:Ensembl. DR GO; GO:0070371; P:ERK1 and ERK2 cascade; IEA:Ensembl. DR GO; GO:0044849; P:estrous cycle; IEA:Ensembl. DR GO; GO:0007565; P:female pregnancy; IBA:GO_Central. DR GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IBA:GO_Central. DR GO; GO:0007507; P:heart development; IEA:Ensembl. DR GO; GO:0007595; P:lactation; TAS:ProtInc. DR GO; GO:0042711; P:maternal behavior; IEA:Ensembl. DR GO; GO:0060137; P:maternal process involved in parturition; IBA:GO_Central. DR GO; GO:0007613; P:memory; IEA:Ensembl. DR GO; GO:0006936; P:muscle contraction; TAS:ProtInc. DR GO; GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl. DR GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab. DR GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl. DR GO; GO:0010701; P:positive regulation of norepinephrine secretion; IEA:Ensembl. DR GO; GO:0060406; P:positive regulation of penile erection; IEA:Ensembl. DR GO; GO:0051965; P:positive regulation of synapse assembly; IEA:Ensembl. DR GO; GO:0032230; P:positive regulation of synaptic transmission, GABAergic; IEA:Ensembl. DR GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IEA:Ensembl. DR GO; GO:0070474; P:positive regulation of uterine smooth muscle contraction; IEA:Ensembl. DR GO; GO:0045907; P:positive regulation of vasoconstriction; IBA:GO_Central. DR GO; GO:0001992; P:regulation of systemic arterial blood pressure by vasopressin; IBA:GO_Central. DR GO; GO:0001975; P:response to amphetamine; IEA:Ensembl. DR GO; GO:0034059; P:response to anoxia; IEA:Ensembl. DR GO; GO:0042220; P:response to cocaine; IEA:Ensembl. DR GO; GO:0034097; P:response to cytokine; IEA:Ensembl. DR GO; GO:0032355; P:response to estradiol; IEA:Ensembl. DR GO; GO:0043434; P:response to peptide hormone; IEA:Ensembl. DR GO; GO:0032570; P:response to progesterone; IEA:Ensembl. DR GO; GO:0009410; P:response to xenobiotic stimulus; IEA:Ensembl. DR GO; GO:0035176; P:social behavior; IEA:Ensembl. DR GO; GO:0042713; P:sperm ejaculation; IEA:Ensembl. DR GO; GO:0001967; P:suckling behavior; IEA:Ensembl. DR GO; GO:0021537; P:telencephalon development; IEA:Ensembl. DR CDD; cd15387; 7tmA_OT_R; 1. DR Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1. DR InterPro; IPR000276; GPCR_Rhodpsn. DR InterPro; IPR017452; GPCR_Rhodpsn_7TM. DR InterPro; IPR002062; Oxytocn_rcpt. DR InterPro; IPR001817; Vasoprsn_rcpt. DR PANTHER; PTHR24241; NEUROPEPTIDE RECEPTOR-RELATED G-PROTEIN COUPLED RECEPTOR; 1. DR PANTHER; PTHR24241:SF89; OXYTOCIN RECEPTOR; 1. DR Pfam; PF00001; 7tm_1; 1. DR PRINTS; PR00237; GPCRRHODOPSN. DR PRINTS; PR00665; OXYTOCINR. DR PRINTS; PR00896; VASOPRESSINR. DR SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1. DR PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1. DR PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1. DR Genevisible; P30559; HS. PE 1: Evidence at protein level; KW 3D-structure; Cell membrane; Disulfide bond; G-protein coupled receptor; KW Glycoprotein; Membrane; Phosphoprotein; Receptor; Reference proteome; KW Transducer; Transmembrane; Transmembrane helix. FT CHAIN 1..389 FT /note="Oxytocin receptor" FT /id="PRO_0000069998" FT TOPO_DOM 1..38 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 39..63 FT /note="Helical; Name=1" FT /evidence="ECO:0000255" FT TOPO_DOM 64..74 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 75..97 FT /note="Helical; Name=2" FT /evidence="ECO:0000255" FT TOPO_DOM 98..113 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 114..135 FT /note="Helical; Name=3" FT /evidence="ECO:0000255" FT TOPO_DOM 136..154 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 155..175 FT /note="Helical; Name=4" FT /evidence="ECO:0000255" FT TOPO_DOM 176..202 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 203..225 FT /note="Helical; Name=5" FT /evidence="ECO:0000255" FT TOPO_DOM 226..275 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 276..294 FT /note="Helical; Name=6" FT /evidence="ECO:0000255" FT TOPO_DOM 295..309 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 310..332 FT /note="Helical; Name=7" FT /evidence="ECO:0000255" FT TOPO_DOM 333..389 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT REGION 7..31 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 361..389 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 366 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P70536" FT MOD_RES 368 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P70536" FT CARBOHYD 8 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 15 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 26 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 112..187 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00521" FT VARIANT 16 FT /note="A -> S (in dbSNP:rs237906)" FT /id="VAR_031570" FT VARIANT 218 FT /note="A -> T (in dbSNP:rs4686302)" FT /evidence="ECO:0000269|PubMed:1313946, ECO:0000269|Ref.3" FT /id="VAR_031571" FT CONFLICT 308 FT /note="A -> G (in Ref. 4; CAA56562)" FT /evidence="ECO:0000305" FT HELIX 36..66 FT /evidence="ECO:0007829|PDB:7RYC" FT HELIX 75..91 FT /evidence="ECO:0007829|PDB:7RYC" FT HELIX 94..101 FT /evidence="ECO:0007829|PDB:7RYC" FT STRAND 102..104 FT /evidence="ECO:0007829|PDB:7RYC" FT HELIX 109..142 FT /evidence="ECO:0007829|PDB:7RYC" FT STRAND 144..146 FT /evidence="ECO:0007829|PDB:6TPK" FT HELIX 150..167 FT /evidence="ECO:0007829|PDB:7RYC" FT TURN 168..170 FT /evidence="ECO:0007829|PDB:7RYC" FT HELIX 171..174 FT /evidence="ECO:0007829|PDB:7RYC" FT STRAND 175..181 FT /evidence="ECO:0007829|PDB:7RYC" FT STRAND 184..189 FT /evidence="ECO:0007829|PDB:7RYC" FT TURN 193..195 FT /evidence="ECO:0007829|PDB:7RYC" FT HELIX 196..208 FT /evidence="ECO:0007829|PDB:7RYC" FT HELIX 210..234 FT /evidence="ECO:0007829|PDB:7RYC" FT TURN 269..273 FT /evidence="ECO:0007829|PDB:7RYC" FT HELIX 274..298 FT /evidence="ECO:0007829|PDB:7RYC" FT HELIX 309..315 FT /evidence="ECO:0007829|PDB:7RYC" FT HELIX 321..331 FT /evidence="ECO:0007829|PDB:7RYC" FT STRAND 332..334 FT /evidence="ECO:0007829|PDB:7RYC" FT HELIX 335..344 FT /evidence="ECO:0007829|PDB:7RYC" FT HELIX 349..351 FT /evidence="ECO:0007829|PDB:6TPK" SQ SEQUENCE 389 AA; 42772 MW; 97E1845DA9676439 CRC64; MEGALAANWS AEAANASAAP PGAEGNRTAG PPRRNEALAR VEVAVLCLIL LLALSGNACV LLALRTTRQK HSRLFFFMKH LSIADLVVAV FQVLPQLLWD ITFRFYGPDL LCRLVKYLQV VGMFASTYLL LLMSLDRCLA ICQPLRSLRR RTDRLAVLAT WLGCLVASAP QVHIFSLREV ADGVFDCWAV FIQPWGPKAY ITWITLAVYI VPVIVLAACY GLISFKIWQN LRLKTAAAAA AEAPEGAAAG DGGRVALARV SSVKLISKAK IRTVKMTFII VLAFIVCWTP FFFVQMWSVW DANAPKEASA FIIVMLLASL NSCCNPWIYM LFTGHLFHEL VQRFLCCSAS YLKGRRLGET SASKKSNSSS FVLSHRSSSQ RSCSQPSTA //